Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03881670 · ClinicalTrials.gov registry record · Phase 4
On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT03881670 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 24 participants.
The verdict
NCT03881670, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The current study aims to systematically investigate the diurnal variation in the optical quality of soft contact lenses on eye throughout the day. Subject reported quality of vision will also be evaluated.
Interventions
- DEVICE Lotrafilcon B
- DEVICE lotrafilcon B with Hydraluxe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2019-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03881670
The ClinicalTrials.gov registry entry for NCT03881670 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lotrafilcon B is the first listed.
NCT03881670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03881670 about?
NCT03881670 is a clinical study titled "On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours". The current study aims to systematically investigate the diurnal variation in the optical quality of soft contact lenses on eye throughout the day. Subject reported quality of vision will also be evaluated.
What is the current status of trial NCT03881670?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2018-12-07. Estimated completion is 2019-02-08.
What interventions are being tested in trial NCT03881670?
The interventions under investigation include: Lotrafilcon B (DEVICE), lotrafilcon B with Hydraluxe (DEVICE).
Who is sponsoring clinical trial NCT03881670?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.